We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Microarray Immunoassay Improves Accuracy and Speed of Celiac Disease Diagnosis

By LabMedica International staff writers
Posted on 05 Sep 2024

Celiac disease is a chronic autoimmune disorder affecting one in every hundred people globally, primarily impacting the small intestine and often presenting with a range of multiorgan symptoms. More...

The disease is characterized by an inappropriate immune response to gluten in individuals who are genetically predisposed, which leads to autoantibody production and damage to the small bowel. The standard diagnostic process includes serological tests for specific autoantibodies, supplemented by other clinical, laboratory, imaging, genetic, and histopathological assessments. Now, a multiplexed microarray immunoassay designed to improve the accuracy and speed of diagnosing celiac disease can help better the lives of affected patients.

AliveDx’s (Eysins, Switzerland) multiplexed MosaiQ AiPlex CD microarray immunoassay provides a novel and efficient solution to streamline the diagnosis process and alleviate the unnecessary burden associated with celiac disease testing. Clinical guidelines suggest screening for IgA autoantibodies against tissue Transglutaminase (anti-tTG IgA) and Deamidated Gliadin Peptides (anti-DGP IgA). Considering the prevalence of selective IgA deficiency among some individuals with celiac disease, assessments of total IgA levels to accompany autoantibody tests are recommended. In instances of IgA deficiency, it is advised to check for pertinent IgG autoantibodies (e.g., anti-tTG IgG, anti-DPG IgG).

The MosaiQ AiPlex CD immunoassay incorporates the most clinically significant autoantibodies, namely tTG IgA, DGP IgA, tTG IgG, and DGP IgG, along with total IgA antibodies detection, offering comprehensive diagnostic insights from a single sample and blood draw. This facilitates laboratories in automating and simplifying the diagnostic process for celiac disease. Following a diagnosis, immediate adoption of a Gluten-Free Diet (GFD) is beneficial for patients, not only in alleviating gastrointestinal symptoms but also in preventing serious long-term health issues. AliveDx’s MosaiQ AiPlex CD microarray immunoassay has been awarded the IVDR-CE mark certification, confirming its safety, efficacy, and readiness for broad clinical application in regions accepting the CE mark.

"We are thrilled to obtain the CE mark for our MosaiQ AiPlex CD microarray," said Manuel O. Mendez, CEO of AliveDx. "The MosaiQ fast portfolio expansion marks our fourth microarray CE mark approval in the last 12 months reflecting our dedication to rapidly advance diagnostic technologies and our commitment to support the millions of individuals affected by autoimmune diseases. Early and accurate diagnosis is crucial for managing this condition. Our innovative MosaiQ microarray solutions represent a significant advancement to partner with laboratorians and clinicians to reduce healthcare costs and improve patient outcomes and quality of life."

Related Links:
AliveDx


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Serological Pipet Controller
PIPETBOY GENIUS
New
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
New
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.